Status:
COMPLETED
The Effect of Exenatide on Fasting Bile Acids
Lead Sponsor:
Beijing Chao Yang Hospital
Conditions:
Type 2 Diabetes Mellitus in Obese
Eligibility:
All Genders
18-65 years
Brief Summary
Newly diagnosed T2DM participants without hypoglycemic drugs intake were retrospective analyzed. Plasma total bile acids in fasting state (FTBAs) and other parameters were compared before and after ex...
Detailed Description
Newly diagnosed T2DM participants without hypoglycemic drugs intake were retrospective analyzed. Plasma total bile acids in fasting state (FTBAs) and other parameters were tested at baseline. Then exe...
Eligibility Criteria
Inclusion
- Newly diagnosed T2DM patients
Exclusion
- History of hepatobiliary or pancreatic diseases
- History of anti-diabetic drugs intake
- Change of anti-dyslipidemia therapy regimen
- Estimated glomerular filtration rate less than 60 mL/min/1.73 m\^2
- Pregnancy
Key Trial Info
Start Date :
January 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04303819
Start Date
January 5 2020
End Date
January 31 2020
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Chao-yang hospital
Beijing, China, 100020